View More 2022, Presenter Profiles, Scientific Sessions

Presenter Profiles: Use of Metabolomics for Assessment of Metabolic Outcomes in Offspring Exposed to Diabetes in Utero: Steps Toward Clinical Applications

|

Estimated Read Time:

1 minute


Use of Metabolomics for Assessment of Metabolic Outcomes in Offspring Exposed to Diabetes in Utero: Steps Toward Clinical Applications

Sunday, June 5 at 6:00 p.m. CT
Hall E-2
Level 1, Ernest N. Morial Convention Center

 

Streaming: On-Demand (after session)


Q&A with Wei Perng, PhD, MPH

Assistant Professor,
Colorado School of Public Health

Wei Perng, PhD, MPH
Wei Perng, PhD, MPH

What is your presentation about?
This presentation discusses the burden of youth-onset metabolic conditions, the challenges of identifying risk factors and mechanisms, the need for precision medicine, and how metabolomics can revolutionize this area of research. The presentation will end with a suggestion of advancements needed to move precision medicine from research towards clinical application.

What makes this topic important in 2022?
A better understanding of risk factors, biomarkers, and mechanisms of youth-onset metabolic disease will directly inform prevention and mitigation strategies.

How did you become involved with this area of diabetes research or care?
I made my way into the field of metabolomics during my postdoctoral fellowship when I was loosed on an untargeted metabolomics dataset in an effort to identify metabolomic profiles of childhood obesity. I have since applied high-dimensional techniques and related analytical approaches to leverage metabolomics as a way to refine exposure assessment, improve understanding of disease mechanisms, and obtain a better understanding of nuances of phenotypes.

What are you most looking forward to at the 82nd Scientific Sessions?
Seeing colleagues in-person after a 2-year hiatus. And of course, the science!

[sub-post-content]